Open AccessClinical observation of local intervention combined with camrelizumab and apatinib in the treatment of metastatic soft-tissue sarcoma
Author(s) -
Yan Li,
Hailiang Li,
Hongtao Hu,
Shanshan Shao,
Chengshi Chen,
Chen-Yang Guo,
Yan Zhao,
Quan-Jun Yao
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1310_21
Subject(s) - apatinib , medicine , adverse effect , soft tissue sarcoma , sarcoma , surgery , clinical endpoint , soft tissue , progression free survival , radiofrequency ablation , ablative case , oncology , chemotherapy , ablation , radiation therapy , randomized controlled trial , pathology
The study aimed to investigate the effectiveness and safety of the combination of immune checkpoint inhibitor, local interventional therapy, and anti-angiogenic therapy in patients with metastatic soft-tissue sarcoma (mSTS).